The Polynovo Ltd (ASX: PNV) share price is racing higher despite no new announcements from the company today.
At the time of writing, the medical device company’s shares are exchanging hands for $1.14 apiece, up 7.55%. Earlier today, the company’s share price reached an intraday high of $1.165.
Polynovo shares stage a comeback
After hitting a multi-year low of 83.5 cents earlier this month, it appears the Polynovo share price has finally bottomed out. This is after a long and arduous 12-month journey in which its shares continually treaded downwards.
Nonetheless, a possible reason behind the recent uptick could be related to the S&P/ASX 200 Healthcare (ASX: XHJ) sector.
Currently, the index has risen 1.67% to 40,017.6 points during early afternoon trade, recording its best day in two weeks.
In addition, a couple of brokers have rated Polynovo shares with varying price points in late February.
The team at Macquarie cut its 12-month price target for Polynovo shares by 44% to $1.60 apiece. This implies a potential upside of 29% from where the company’s shares are trading today.
Furthermore, analysts at Wilsons dropped their outlook on Polynovo shares by 22% to $1.11 each. It appears the broker is on the mark as to where the medical company’s shares are valued.
Polynovo share price summary
When looking year to date, the Polynovo share price has lost almost 25% in value for shareholders.
However, over the past 12 months, its losses have magnified to around 60%.
Based on today’s price, Polynovo presides a market capitalisation of about $751 million.
The post What’s driving the Polynovo (ASX:PNV) share price higher today? appeared first on The Motley Fool Australia.
Should you invest $1,000 in Polynovo right now?
Before you consider Polynovo, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Polynovo wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of January 13th 2022
More reading
- These are the 10 most shorted ASX shares
- Polynovo (ASX:PNV) share price spikes 7% as healthcare stages comeback rally
- These are the 10 most shorted ASX shares
- These were the best performing ASX 200 share last week
- The Polynovo (ASX:PNV) share price has lost 35% this year. Is now the time to buy?
Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended POLYNOVO FPO. The Motley Fool Australia has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/9TAXWZs
Leave a Reply